Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synflorix Booster in 4th Year of Life
NCT00792909Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2008
- Primary completion
- Jul 2009
- Modality
- Split/Subunit Vaccines
- Countries
- 2
01
Overview
Phase 3, open-label trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection (3 arms), sponsored by GSK. Primary endpoint: Antibody Geometric Mean Concentrations. Started Dec 2008; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00792909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00792909.